Innovation Sourcing VIC Tech's strong partnerships with leading research institutions worldwide enable continuous access to high-impact, early-stage life science technologies. This positions them as a prime partner for companies seeking licensing opportunities or collaboration in cutting-edge therapeutics, medical devices, and diagnostics.

Portfolio Growth With a track record of rapid value creation and a focus on commercialization support, VIC Tech actively advances its portfolio companies toward exit via acquisition. This creates opportunities for acquirers and investors interested in high-growth biomedical ventures at various development stages.

Geographic Expansion Recent expansion into Minnesota and nationwide operations broadens VIC Tech's footprint, paving the way for local and regional partners to engage in the burgeoning North American life science market, especially in medical device and therapeutics sectors.

Funding & Investment VIC Tech manages an active investor network offering vetted opportunities with attractive early-stage valuations. This network is a potential channel for partners seeking strategic investments or co-investment opportunities in innovative life science companies.

Leadership & Expertise The company's recent appointments to its board and advisory boards bring seasoned leadership and domain expertise, creating opportunities for strategic collaborations, consulting, and joint ventures with established industry authorities.